KIMEN COLGAN: Open Payments
NPI 1699739227 · PISMO BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 24 payments from 9 companies in 2025. Trend: 2023 $361 · 2024 $470 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $156 |
| Eisai Inc. | 4 | $85 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Janssen Biotech, Inc. | 3 | $46 |
| Genentech USA, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $17 |
| Incyte Corporation | 1 | $14 |
Products named: LYNPARZA, Lenvima, KEYTRUDA, ENHERTU, Polivy, TALVEY, Nubeqa, PYRUKYND.
Industry payments across CA — which companies pay providers there.
